Boehringer Ingelheim advances obesity drug candidate with up to 19% weight loss in mid-stage trial
Germany’s Boehringer Ingelheim said on Thursday it would conduct three late-stage studies...
Read MoreGermany’s Boehringer Ingelheim said on Thursday it would conduct three late-stage studies...
Read More